Factors impacting quality of life in multiple system atrophy
BackgroundMultiple system atrophy (MSA) is an atypical parkinsonian disorder marked by autonomic dysfunction, parkinsonism, cerebellar dysfunction, and poor response to dopaminergic medications such as levodopa. Patient-reported quality of life is an important benchmark for clinicians and clinical t...
Main Authors: | Nabila Ali, Vanessa Nesspor, Jee Bang, Sonja W. Scholz, Alexander Pantelyat |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1111605/full |
Similar Items
-
The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
by: Hai-Yan Zhou, et al.
Published: (2018-07-01) -
Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
by: Lisa Mészáros, et al.
Published: (2020-04-01) -
Rhythmic auditory cueing in atypical parkinsonism: A pilot study
by: Alexander Pantelyat, et al.
Published: (2022-10-01) -
Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study
by: Rachel Rohmann, et al.
Published: (2021-06-01) -
Neuropsychiatric and cognitive changes in Parkinson's disease and related movement disorders : diagnosis and management /
by: Aarsland, Dag, et al.
Published: (2013)